We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Grants Roche’s Cancer Immunotherapy Tecentriq Accelerated Approval

News   May 20, 2016

 
FDA Grants Roche’s Cancer Immunotherapy Tecentriq Accelerated Approval
 
 
 

RELATED ARTICLES

Cancer Risk Increases If Overweight Before 40

News

New research has demonstrated that overweight and adults have an increased risk of postmenopausal breast, endometrial, renal-cell and colon cancer.

READ MORE

Imaging Tumor Stiffness To Enhance Breast and Pancreatic Cancer Treatments

News

Using a non-invasive imaging technique that measures the stiffness of tissues gives vital new information about cancer architecture and could aid the delivery of treatment to challenging tumors.

READ MORE

Two $1 Million Research Grants Focus on Metastasis of Melanoma

News

Two new grants will support interdisciplinary teams to better understand and manage metastasis of melanoma and other types of cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE